Alejandro A Schäffer1, Christoph Klein. 1. Computational Biology Branch, National Center for Biotechnology Information, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA.
Abstract
PURPOSE OF REVIEW: Severe congenital neutropenia is a primary immunodeficiency in which lack of neutrophils causes inadequate innate immune host response to bacterial infections. Severe congenital neutropenia occurs with sporadic, autosomal dominant, autosomal recessive and X-linked recessive inheritance, as well as in a variety of multisystem syndromes. A principal stimulus for this review is the identification of novel genetic defects and pathophysiological insights into the role of neutrophil apoptosis. RECENT FINDINGS: The recent findings include identification of mutations in HAX1 in autosomal recessive severe congenital neutropenia (Kostmann disease), a large epidemiological study estimating the risk of progression from severe congenital neutropenia to leukemia, a better understanding of how heterozygous mutations in neutrophil elastase (ELA2) cause severe congenital neutropenia, molecular characterization of a novel syndromic form of severe congenital neutropenia called p14 deficiency and new animal models for several syndromic forms of severe congenital neutropenia. SUMMARY: We consider the numerous genes mutated in severe congenital neutropenia, the many attempts to make animal models of severe congenital neutropenia, and the results from both human and mouse studies investigating the molecular mechanisms of neutrophil apoptosis. Investigations of how severe congenital neutropenia genes and apoptosis pathways are connected should lead to a better understanding of the pathogenesis of neutropenia and apoptosis pathways relevant to many cell types.
PURPOSE OF REVIEW: Severe congenital neutropenia is a primary immunodeficiency in which lack of neutrophils causes inadequate innate immune host response to bacterial infections. Severe congenital neutropenia occurs with sporadic, autosomal dominant, autosomal recessive and X-linked recessive inheritance, as well as in a variety of multisystem syndromes. A principal stimulus for this review is the identification of novel genetic defects and pathophysiological insights into the role of neutrophil apoptosis. RECENT FINDINGS: The recent findings include identification of mutations in HAX1 in autosomal recessive severe congenital neutropenia (Kostmann disease), a large epidemiological study estimating the risk of progression from severe congenital neutropenia to leukemia, a better understanding of how heterozygous mutations in neutrophil elastase (ELA2) cause severe congenital neutropenia, molecular characterization of a novel syndromic form of severe congenital neutropenia called p14deficiency and new animal models for several syndromic forms of severe congenital neutropenia. SUMMARY: We consider the numerous genes mutated in severe congenital neutropenia, the many attempts to make animal models of severe congenital neutropenia, and the results from both human and mouse studies investigating the molecular mechanisms of neutrophil apoptosis. Investigations of how severe congenital neutropenia genes and apoptosis pathways are connected should lead to a better understanding of the pathogenesis of neutropenia and apoptosis pathways relevant to many cell types.
Authors: Hanno Hock; Melanie J Hamblen; Heather M Rooke; David Traver; Roderick T Bronson; Scott Cameron; Stuart H Orkin Journal: Immunity Date: 2003-01 Impact factor: 31.745
Authors: Gianluca Fossati; Dale A Moulding; David G Spiller; Robert J Moots; Michael R H White; Steven W Edwards Journal: J Immunol Date: 2003-02-15 Impact factor: 5.422
Authors: Graeme R B Boocock; Jodi A Morrison; Maja Popovic; Nicole Richards; Lynda Ellis; Peter R Durie; Johanna M Rommens Journal: Nat Genet Date: 2002-12-23 Impact factor: 38.330
Authors: David S Grenda; Sonja E Johnson; Jill R Mayer; Morgan L McLemore; Kathleen F Benson; Marshall Horwitz; Daniel C Link Journal: Blood Date: 2002-11-01 Impact factor: 22.113
Authors: Chien-Ying Liu; Akihiro Takemasa; W Conrad Liles; Richard B Goodman; Mechthild Jonas; Henry Rosen; Emil Chi; Robert K Winn; John M Harlan; Peter I Chuang Journal: Blood Date: 2002-06-28 Impact factor: 22.113
Authors: Stephen J Salipante; Meghan E B Rojas; Brice Korkmaz; Zhijun Duan; Jeremy Wechsler; Kathleen F Benson; Richard E Person; H Leighton Grimes; Marshall S Horwitz Journal: Mol Cell Biol Date: 2009-06-08 Impact factor: 4.272
Authors: Thierry Vilboux; Atar Lev; May Christine V Malicdan; Amos J Simon; Päivi Järvinen; Tomas Racek; Jacek Puchalka; Raman Sood; Blake Carrington; Kevin Bishop; James Mullikin; Marjan Huizing; Ben Zion Garty; Eran Eyal; Baruch Wolach; Ronit Gavrieli; Amos Toren; Michalle Soudack; Osama M Atawneh; Tatiana Babushkin; Ginette Schiby; Andrew Cullinane; Camila Avivi; Sylvie Polak-Charcon; Iris Barshack; Ninette Amariglio; Gideon Rechavi; Jutte van der Werff ten Bosch; Yair Anikster; Christoph Klein; William A Gahl; Raz Somech Journal: N Engl J Med Date: 2013-06-05 Impact factor: 91.245
Authors: Kaan Boztug; Giridharan Appaswamy; Angel Ashikov; Alejandro A Schäffer; Ulrich Salzer; Jana Diestelhorst; Manuela Germeshausen; Gudrun Brandes; Jacqueline Lee-Gossler; Fatih Noyan; Anna-Katherina Gatzke; Milen Minkov; Johann Greil; Christian Kratz; Theoni Petropoulou; Isabelle Pellier; Christine Bellanné-Chantelot; Nima Rezaei; Kirsten Mönkemöller; Noha Irani-Hakimeh; Hans Bakker; Rita Gerardy-Schahn; Cornelia Zeidler; Bodo Grimbacher; Karl Welte; Christoph Klein Journal: N Engl J Med Date: 2009-01-01 Impact factor: 91.245
Authors: Marton Keszei; Julien Record; Joanna S Kritikou; Hannah Wurzer; Chiara Geyer; Meike Thiemann; Paul Drescher; Hanna Brauner; Laura Köcher; Jaime James; Minghui He; Marisa Ap Baptista; Carin Im Dahlberg; Amlan Biswas; David P Lane; Wenxia Song; Katrin Pütsep; Peter Vandenberghe; Scott B Snapper; Lisa S Westerberg Journal: J Clin Invest Date: 2018-08-20 Impact factor: 14.808